Table 3

Impact of pulmonary rehabilitation on symptoms and quality of life

Placebo BRJ (n=64)Nitrate-rich BRJ (n=53)Treatment effect95% CIP value
ΔMRC dyspnoea score0.0 (−1.0, 0.0)−1.0 (−1.0, −0.0)00 to 00.90
ΔHADS-Anxiety−1.0 (−3.0, 0.8)−1.0 (−2.0, 0.3)0−1 to 10.58
ΔHADS-Depression−1.0 (−2.8, 1.0)−1.0 (−3.0, 1.0)0−1 to 10.51
ΔCAT score−2.0 (−7.0, 1.0)−2.5 (−5.0, 0.0)0−1 to 30.74
  • Data shown are median (IQR). P values are for Mann-Whitney U test between study arms. Treatment effect was tested using Hodges-Lehmann estimates of shift parameters.

  • BRJ, beetroot juice; CAT, COPD Assessment Test; HADS, Hospital Anxiety and Depression Scale; MRC, Medical Research Council.